INSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille, France.
University of Lille, Lille University Hospital, Lille, France.
Diabetes Care. 2023 Sep 1;46(9):1707-1714. doi: 10.2337/dc22-2373.
Depression is a common comorbidity of type 2 diabetes. We assessed the causal relationships and shared genetics between them.
We applied two-sample, bidirectional Mendelian randomization (MR) to assess causality between type 2 diabetes and depression. We investigated potential mediation using two-step MR. To identify shared genetics, we performed 1) genome-wide association studies (GWAS) separately and 2) multiphenotype GWAS (MP-GWAS) of type 2 diabetes (19,344 case subjects, 463,641 control subjects) and depression using major depressive disorder (MDD) (5,262 case subjects, 86,275 control subjects) and self-reported depressive symptoms (n = 153,079) in the UK Biobank. We analyzed expression quantitative trait locus (eQTL) data from public databases to identify target genes in relevant tissues.
MR demonstrated a significant causal effect of depression on type 2 diabetes (odds ratio 1.26 [95% CI 1.11-1.44], P = 5.46 × 10-4) but not in the reverse direction. Mediation analysis indicated that 36.5% (12.4-57.6%, P = 0.0499) of the effect from depression on type 2 diabetes was mediated by BMI. GWAS of type 2 diabetes and depressive symptoms did not identify shared loci. MP-GWAS identified seven shared loci mapped to TCF7L2, CDKAL1, IGF2BP2, SPRY2, CCND2-AS1, IRS1, CDKN2B-AS1. MDD has not brought any significant association in either GWAS or MP-GWAS. Most MP-GWAS loci had an eQTL, including single nucleotide polymorphisms implicating the cell cycle gene CCND2 in pancreatic islets and brain and the insulin signaling gene IRS1 in adipose tissue, suggesting a multitissue and pleiotropic underlying mechanism.
Our results highlight the importance to prevent type 2 diabetes at the onset of depressive symptoms and the need to maintain a healthy weight in the context of its effect on depression and type 2 diabetes comorbidity.
抑郁症是 2 型糖尿病常见的合并症。我们评估了它们之间的因果关系和共同遗传基础。
我们应用两样本双向孟德尔随机化(MR)来评估 2 型糖尿病和抑郁症之间的因果关系。我们使用两步 MR 来研究潜在的中介作用。为了确定共同的遗传基础,我们进行了 1)分别进行全基因组关联研究(GWAS)和 2)使用 UK Biobank 中的主要抑郁障碍(MDD)(5262 例病例,86275 例对照)和自我报告的抑郁症状(n=153079)的多表型 GWAS(MP-GWAS)对 2 型糖尿病进行分析。我们分析了公共数据库中的表达数量性状基因座(eQTL)数据,以确定相关组织中的靶基因。
MR 表明,抑郁症对 2 型糖尿病有显著的因果影响(比值比 1.26 [95%CI 1.11-1.44],P=5.46×10-4),但反之则没有。中介分析表明,抑郁症对 2 型糖尿病的影响中有 36.5%(12.4-57.6%,P=0.0499)是通过 BMI 介导的。2 型糖尿病和抑郁症状的 GWAS 未发现共同的位点。MP-GWAS 确定了七个共同的位点,这些位点映射到 TCF7L2、CDKAL1、IGF2BP2、SPRY2、CCND2-AS1、IRS1 和 CDKN2B-AS1。MDD 在 GWAS 或 MP-GWAS 中均未带来显著关联。大多数 MP-GWAS 位点都有一个 eQTL,包括单核苷酸多态性,这些多态性暗示了细胞周期基因 CCND2 在胰腺胰岛和大脑中的作用,以及胰岛素信号基因 IRS1 在脂肪组织中的作用,表明存在多组织和多效性的潜在机制。
我们的研究结果强调了在抑郁症状出现时预防 2 型糖尿病的重要性,以及在其对抑郁和 2 型糖尿病合并症的影响下保持健康体重的必要性。